GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sirona Biochem Corp (FRA:ZSB) » Definitions » Debt-to-Revenue

Sirona Biochem (FRA:ZSB) Debt-to-Revenue : 401.25 (As of Jan. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Sirona Biochem Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Sirona Biochem's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €0.54 Mil. Sirona Biochem's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jan. 2024 was €1.06 Mil. Sirona Biochem's annualized Revenue for the quarter that ended in Jan. 2024 was €0.00 Mil. Sirona Biochem's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 was 401.25.


Sirona Biochem Debt-to-Revenue Historical Data

The historical data trend for Sirona Biochem's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sirona Biochem Debt-to-Revenue Chart

Sirona Biochem Annual Data
Trend Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.41 11.74 3.17 0.70 62.83

Sirona Biochem Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 6.51 56.80 N/A 401.25

Competitive Comparison of Sirona Biochem's Debt-to-Revenue

For the Biotechnology subindustry, Sirona Biochem's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sirona Biochem's Debt-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sirona Biochem's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Sirona Biochem's Debt-to-Revenue falls into.



Sirona Biochem Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Sirona Biochem's Debt-to-Revenue for the fiscal year that ended in Oct. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.445 + 1.063) / 0.024
=62.83

Sirona Biochem's annualized Debt-to-Revenue for the quarter that ended in Jan. 2024 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0.541 + 1.064) / 0.004
=401.25

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Jan. 2024) Revenue data.


Sirona Biochem Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sirona Biochem's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Sirona Biochem (FRA:ZSB) Business Description

Traded in Other Exchanges
Address
C/o WeWork, 595 Burrard Street, Vancouver, BC, CAN, V7X 1L3
Sirona Biochem Corp is a development stage biotechnology company. The principal activities of the company are the development of cosmetic and pharmaceutical active ingredients which are licensed to partners in exchange for upfront, milestone, and royalty payments. The company acts as a cosmetic ingredient and drug discovery company with a proprietary technology platform with a specialization in the stabilization of carbohydrate molecules. It has a business presence in Canada and France.

Sirona Biochem (FRA:ZSB) Headlines

No Headlines